Prof Kevin Baird


J. Kevin Baird, BSc MSc PhD FASTMH


Head of Unit, Eijkman-Oxford Clinical Research Unit, Jakarta.


Professor Baird  is the Head of Eijkman-Oxford Clinical Research Unit. He earned a B.Sc. in Microbiology, M.Sc. in Biochemistry from University of Maryland,Ph.D. in Medical Zoology from Tulane University and Professor of Malariology from University of Oxford. He has long focused on Plasmodium vivax malaria, in particular on the problem of G6PD deficiency and primaquine therapy against relapse of that species. EOCRU undertakes clinical trials of therapies against relapse of P. vivax, principally in Indonesian soldiers but also in village settings, in addition to laboratory and field studies of G6PD deficiency biochemistry, diagnostics, and epidemiology.


Professor Baird has published over 140 technical articles and 80 reviews, chapters and letters.

Key technical articles

Nelwan EJ, Ekawati LL, Tjahjono B, Setiabudy R, Sutanto I, Chand K, Ekasari T, Djoko D, Basri H, Taylor WR, Duparc S, Subekti D, Elyazar I, Noviyanti R, Sudoyo H, Baird JK. 2015. Randomized trial of primaquine hypnozoitocidal efficacy when administered with artemisinin-combined blood schizontocides for radical cure of Plasmodium vivax in Indonesia. BMC Medicine 13: 294.

Satyagraha AW, Sadhewa A, Elvira R, Feiandika D, Antonjaya U, Oyong D, Elyazar I, Subekti D, Domingo G, Harahap AR, Baird JK. 2016. Assessment of point-of-care diagnostics for G6PD deficiency in malaria endemic rural eastern Indonesia. PLoS Negl Trop Dis 10: e0004457.

Sutanto I, Tjahjono B, Basri H, Taylor WR, Putri FA, Melia RA, Setiabudy R, Nurliela S, Ekawati LL, Elyazar I, Farrar J, Sodoyo H, Baird JK. 2013. Randomized, open-label trial of primaquine against vivax malaria relapse in Indonesia. Antimicrob Agents Chemother 57: 1128-1135.-

Nurleila S, Syarfuddin D, Elyazar IR, Baird JK. 2012. Serious and fatal illness associated with falciparum and vivax malaria among patients admitted to hospital at West Sumba, Indonesia. Am J Trop Med Hyg 87: 41-9-

Valecha N, Pinto RGW, Turner GDH, Kumar A, Rodrigues S, Dubhashi NG, Rodrigues E, Banaulikar SS, Singh R, Dash AP, Baird JK. 2009. Histopathology of fatal respiratory distress caused by Plasmodium vivax malaria. American Journal of Tropical Medicine & Hygiene 81:758-762-

Key books/monographs etc

Baird JK. 2017. Malaria control by commodities without practical malariology. BMC Public Health, In press.

Nguyen TD, Olliaro P, Dondorp AM, Baird JK, Lam HM, Farrar J, Thwaites GE, White NJ, Boni MF. 2016. Optimum population-level use of artemisinin-combined therapies: a modelling study. Lancet Global Health 2015; 3: e758-766.

Baird JK. 2015. G6PD diagnostics for Plasmodium vivax malaria is clinical and public health urgency. BMC Medicine 13: 296.

Baird JK. 2013. Evidence and implications of mortality associated with acute Plasmodium vivax malaria. Clinical Microbiology Reviews 26: 36-57.

Hay SI, Price R, Baird JK (eds). The Epidemiology of Plasmodium vivax: History, Hiatus, and Hubris, Parts A & B. Advances in Parasitology 2012 & 2013, volumes 80 & 81, 356 & 267 pp.

Doolan DL, Dobano C, Baird JK. 2009. Acquired immunity to malaria. Clinical Microbiological Reviews 22: 13-36.

Baird JK. 2009. Resistance to therapies for Plasmodium vivax. Clinical Microbiology Reviews 22: 508-34.

Baird JK. 2005. Effectiveness of antimalarial drugs. New England Journal of Medicine 352: 1565-77.

Dr Baird’s Google Scholar profile